Merck is testing a confluence of potential chart support near the $55 level. The stock of pharmaceutical company Merck (ticker, MRK) has been bloodied a…
Merck is testing a confluence of potential chart support near the $55 level. The stock of pharmaceutical company Merck (ticker, MRK) has been bloodied a…
The compliment to “Sell in May and Go Away” doesn’t have a catchy jingle, but the historically best 6-month stretch of the year for stocks…
An index of coal-related stocks is hitting key long-term resistance. Aside from banks and other stocks related to the housing market, another poster child of…
Assets in mutual funds designed to rise when stocks fall have dropped to an all-time low. In the Northern hemisphere here, bears typically begin their…
On the 30-year anniversary of Black Monday, we take a look at the magnitude of the crash in terms of today’s market. By now, you’ve…
While the S&P 500 his on an impressive string of new highs, a number of them have come on questionable breadth. When it comes to…
A key barometer of worldwide developed markets is bumping up against 9-year highs. While the U.S. stock rally is getting a lot of (deserved) attention…
There has only been one trading range in the history of the Russell 2000 tighter than the current one — and it immediately preceded a…
The following guest post is a first-hand account of the events surrounding the Crash of 1987 by JLFMI President, John S. Lyons. Personal Recollections…
The 4th quarter of years ending in “7″ have historically exhibited the stock market’s worst quarterly performance of the decadal cycle. Exactly 3 months ago, we…